{"id":"https://openalex.org/W2980378992","doi":"https://doi.org/10.1016/j.clml.2019.09.463","title":"The clinical course of multiple myeloma in the era of novel agents: a retrospective, single-center, real-world study","display_name":"The clinical course of multiple myeloma in the era of novel agents: a retrospective, single-center, real-world study","alternate_titles":[],"publication_year":2019,"publication_date":"2019-10-01","ids":{"openalex":"https://openalex.org/W2980378992","doi":"https://doi.org/10.1016/j.clml.2019.09.463","mag":"2980378992"},"language":"en","primary_location":{"id":"doi:10.1016/j.clml.2019.09.463","doi":"https://doi.org/10.1016/j.clml.2019.09.463","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clml.2019.09.463","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2980378992"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004265858","display_name":"Agoston Gyula Szabo","orcid":"https://orcid.org/0000-0001-9943-7007","observed_orcids":["https://orcid.org/0000-0001-9943-7007"]},"institutions":[{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Agoston Gyula Szabo","raw_affiliation_strings":["Vejle Hospital, Vejle, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vejle Hospital, Vejle, Denmark","institution_ids":["https://openalex.org/I4210091196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000943471","display_name":"Katrine Fladeland Iversen","orcid":"https://orcid.org/0000-0003-4494-9034","observed_orcids":["https://orcid.org/0000-0003-4494-9034"]},"institutions":[{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Katrine Fladeland Iversen","raw_affiliation_strings":["Vejle Hospital, Vejle, Vejle"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vejle Hospital, Vejle, Vejle","institution_ids":["https://openalex.org/I4210091196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050798633","display_name":"S\u00f6ren M\u00f6ller","orcid":"https://orcid.org/0000-0003-0858-4269","observed_orcids":["https://orcid.org/0000-0003-0858-4269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S\u00f6ren M\u00f6ller","raw_affiliation_strings":["Open Patient Data Explorative Network, Odense C, Odense"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Open Patient Data Explorative Network, Odense C, Odense","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028707750","display_name":"Torben Plesner","orcid":"https://orcid.org/0000-0002-2340-6068","observed_orcids":["https://orcid.org/0000-0002-2340-6068"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]},{"id":"https://openalex.org/I4210091196","display_name":"Vejle Sygehus","ror":"https://ror.org/00e8ar137","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210091196","https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Torben Plesner","raw_affiliation_strings":["University of Southern Denmark, Center Little Belt, Vejle Hospital, Vejle, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern Denmark, Center Little Belt, Vejle Hospital, Vejle, Denmark","institution_ids":["https://openalex.org/I177969490","https://openalex.org/I4210091196"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1900,"currency":"USD","value_usd":1900},"apc_paid":null,"fwci":0.6876,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.6909311,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"19","issue":"10","first_page":"e281","last_page":"e281"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/novel-agents","display_name":"novel agents","score":0.6769999861717224},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.906000018119812},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.8519999980926514},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7710000276565552},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6679999828338623},{"id":"https://openalex.org/keywords/treatment-lines","display_name":"treatment lines","score":0.7350000143051147},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.5429999828338623},{"id":"https://openalex.org/keywords/bortezomib-dexamethasone","display_name":"bortezomib-dexamethasone","score":0.8880000114440918},{"id":"https://openalex.org/keywords/lenalidomide-dexamethasone","display_name":"lenalidomide-dexamethasone","score":0.953000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9372051954269409},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.8526781797409058},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7174333333969116},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.6719647645950317},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.6129908561706543},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6128290891647339},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6007251143455505},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5558079481124878},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5115724205970764},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.45882344245910645},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.418215811252594},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3723480701446533},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36685308814048767},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2728736996650696}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clml.2019.09.463","doi":"https://doi.org/10.1016/j.clml.2019.09.463","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clml.2019.09.463","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},{"id":"pmh:oai:sdu.dk:openaire_cris_publications/6e982422-1ad8-4425-bee0-b374bd2551c8","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/6e982422-1ad8-4425-bee0-b374bd2551c8","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Szabo, A G, Iversen, K F, Moller, S & Plesner, T 2019, 'The clinical course of multiple myeloma in the era of novel agents: a retrospective, single-center, real-world study', Clinical Lymphoma Myeloma and Leukemia, vol. 19, no. 10 Supplement, pp. E281. https://doi.org/10.1016/j.clml.2019.09.463","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408483265","https://openalex.org/W2743526294","https://openalex.org/W2799309776","https://openalex.org/W2915924838","https://openalex.org/W2800176807","https://openalex.org/W3154024747","https://openalex.org/W4405050812","https://openalex.org/W2518740313","https://openalex.org/W2245292597","https://openalex.org/W4386052266"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2980378992","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-10-25T00:00:00"}
